634
Views
0
CrossRef citations to date
0
Altmetric
Research Article

Outcomes of minimal access retroperitoneal para-aortic lymphadenectomy in patients with locally advanced cervical cancer

, , , , , , , , , , , , & ORCID Icon show all
Article: 2344529 | Received 03 Mar 2023, Accepted 20 May 2024, Published online: 06 May 2024

References

  • Bhatla, N., et al., 2019. Revised FIGO staging for carcinoma of the cervix uteri. International Journal of Gynaecology and Obstetrics, 145 (1), 1–8.
  • Cheung, T.H., et al., 2011. Debulking metastatic pelvic nodes before radiotherapy in cervical cancer patients: a long-term follow-up result. International Journal of Clinical Oncology, 16 (5), 546–552.
  • Cibula, D., et al., 2023. ESGO/ESTRO/ESP Guidelines for the management of patients with cervical cancer – Update 2023. International Journal of Gynecologic Cancer, 33 (5), 649–666.
  • Clavien, P.A., Sanabria, J.R. and Strasberg, S.M., 1992. Proposed classification of complications of surgery with examples of utility in cholecystectomy. Surgery, 111 (5), 518–526.
  • Cosin, J.A., et al., 1998. Pretreatment surgical staging of patients with cervical carcinoma: the case for lymph node debulking. Cancer, 82 (11), 2241–2248.
  • Del Pino, M., et al., 2013. Laparoscopic lymphadenectomy in advanced cervical cancer: prognostic and therapeutic value. International Journal of Gynecological Cancer, 23 (9), 1675–1683.
  • Denschlag, D., et al., 2005. Evaluation of patients after extraperitoneal lymph node dissection for cervical cancer. Gynecologic Oncology, 96 (3), 658–664.
  • Gil-Moreno, A., et al., 2011. Pretherapeutic extraperitoneal laparoscopic staging of bulky or locally advanced cervical cancer. Annals of Surgical Oncology, 18 (2), 482–489.
  • Haie, C., et al., 1988. Feasibility study of an alternating schedule of radiotherapy and chemotherapy in advanced uterine cervical carcinoma. Radiotherapy and Oncology, 12 (2), 121–127.
  • Holcomb, K., et al., 1999. The impact of pretreatment staging laparotomy on survival in locally advanced cervical carcinoma. European Journal of Gynaecological Oncology, 20 (2), 90–93.
  • Hong, D.G., et al., 2010. Survival benefit of laparoscopic surgical staging-guided radiation therapy in locally advanced cervical cancer. Journal of Gynecologic Oncology, 21 (3), 163–168.
  • Iyer, R., et al., 2015. Predictors of complications in gynaecological oncological surgery: a prospective multicentre study (UKGOSOC-UK gynaecological oncology surgical outcomes and complications). British Journal of Cancer, 112 (3), 475–484.
  • Jolly, S., et al., 2018. Improving Global Outcomes in Cervical Cancer: The Time Has Come for International Federation of Gynecology and Obstetrics Staging to Formally Incorporate Advanced Imaging. Journal of Global Oncology, 4, 1–6.
  • Keys, H. M., 3rd., et al., 1999. Cisplatin, radiation, and adjuvant hysterectomy compared with radiation and adjuvant hysterectomy for bulky stage IB cervical carcinoma. The New England Journal of Medicine, 340 (15), 1154–1161.
  • Kupets, R., Thomas, G.M. and Covens, A., 2002. Is there a role for pelvic lymph node debulking in advanced cervical cancer? Gynecologic Oncology, 87 (2), 163–170.
  • Lai, C.-H., et al., 2003. Randomized trial of surgical staging (extraperitoneal or laparoscopic) versus clinical staging in locally advanced cervical cancer. Gynecologic Oncology, 89 (1), 160–167.
  • Lanciano, R.M. and Corn, B.W., 1994. The Role of Surgical Staging for Cervical Cancer. Seminars in Radiation Oncology, 4 (1), 46–51.
  • Leblanc, E., et al., 2007. Therapeutic value of pretherapeutic extraperitoneal laparoscopic staging of locally advanced cervical carcinoma. Gynecologic Oncology, 105 (2), 304–311.
  • Leblanc, E., et al., 2011. Accuracy of 18-fluoro-2-deoxy-D-glucose positron emission tomography in the pretherapeutic detection of occult para-aortic node involvement in patients with a locally advanced cervical carcinoma. Annals of Surgical Oncology, 18 (8), 2302–2309.
  • Leblanc, E., et al., 2016. Should systematic infrarenal para-aortic dissection be the rule in the pretherapeutic staging of primary or recurrent locally advanced Cervix cancer patients with a negative preoperative para-aortic PET Imaging? International Journal of Gynecological Cancer, 26 (1), 169–175.
  • Liu, B., Gao, S. and Li, S., 2017. A comprehensive comparison of CT, MRI, positron emission tomography or positron emission tomography/CT, and diffusion weighted imaging-MRI for detecting the lymph nodes metastases in patients with cervical cancer: a meta-analysis based on 67 studies. Gynecologic and Obstetric Investigation, 82 (3), 209–222.
  • Luo, Q., Luo, L. and Tang, L., 2018. A network meta-analysis on the diagnostic value of different imaging methods for Lymph Node metastases in patients with cervical cancer. Technology in Cancer Research & Treatment, 17, 1533034617742311. PMID: 29343205; PMCID: PMC5784560.
  • Marnitz, S., et al., 2005. Is there a benefit of pretreatment laparoscopic transperitoneal surgical staging in patients with advanced cervical cancer? Gynecologic Oncology, 99 (3), 536–544.
  • Marnitz, S., et al., 2020. Surgical versus clinical staging prior to primary chemoradiation in patients with cervical cancer FIGO stages IIB-IVA: oncologic results of a prospective randomized international multicenter (Uterus-11) intergroup study. International Journal of Gynecological Cancer, 30 (12), 1855–1861. Dec PMID: 33293284; PMCID: PMC7788482.
  • Martinez, A. et al., 2023. PARa-aOrtic LymphAdenectomy in locally advanced cervical cancer (PAROLA trial): a GINECO, ENGOT, and GCIG study. International Journal of Gynecologic Cancer, 33 (2), 293–298.
  • Morris, M., et al., 1999. Pelvic radiation with concurrent chemotherapy compared with pelvic and para-aortic radiation for high-risk cervical cancer. The New England Journal of Medicine, 340 (15), 1137–1143.
  • Rajasooriyar, C., et al., 2011. Patterns of failure and treatment-related toxicity in advanced cervical cancer patients treated using extended field radiotherapy with curative intent. International Journal of Radiation Oncology, Biology, Physics, 80 (2), 422–428.
  • Rotman, M., et al., 1995. Prophylactic extended-field irradiation of para-aortic lymph nodes in stages IIB and bulky IB and IIA cervical carcinomas. Ten-year treatment results of RTOG 79-20. JAMA, 274 (5), 387–393.
  • Small, W., et al., 2011. Extended-field irradiation and intracavitary brachytherapy combined with cisplatin and amifostine for cervical cancer with positive para-aortic or high common iliac lymph nodes: results of arm II of Radiation Therapy Oncology Group (RTOG) 0116. International Journal of Gynecological Cancer, 21 (7), 1266–1275.
  • Selman, T.J., et al., 2008. Diagnostic accuracy of tests for lymph node status in primary cervical cancer: a systematic review and meta-analysis. CMAJ: Canadian Medical Association Journal = Journal de L’Association Medicale Canadienne, 178 (7), 855–862.
  • Smits, R.M., Zusterzeel, P.L. and Bekkers, R.L., 2014. Pretreatment retroperitoneal para-aortic lymph node staging in advanced cervical cancer: a review. International Journal of Gynecological Cancer, 24 (6), 973–983. Jul PMID: 24978708.
  • Sonoda, Y., et al., 2003. Prospective evaluation of surgical staging of advanced cervical cancer via a laparoscopic extraperitoneal approach. Gynecologic Oncology, 91 (2), 326–331.
  • Tammela, J., Bundy, B. and Odunsi, K., 2004. Reassessment of pelvic lymph node debulking in advanced cervical cancer. Gynecologic Oncology, 92 (3), 1014–1015.
  • Tax, C., et al., 2018. Para-aortic lymphadenectomy in advanced stage cervical cancer, a protocol for comparing safety, feasibility and diagnostic accuracy of surgical staging versus PET-CT; PALDISC trial. Pilot and Feasibility Studies, 4 (1), 27.
  • Vinh-Hung, V., et al., 2007. Prognostic value of histopathology and trends in cervical cancer: a SEER population study. BMC Cancer, 7 (1), 164. PMID: 17718897; PMCID: PMC1994954.